SARAH ARNOLD: Open Payments
NPI 1649889577 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $43 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $150 |
| GENZYME CORPORATION | 3 | $52 |
| Grifols USA, LLC | 2 | $49 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: REZDIFFRA, DUPIXENT, Prolastin-C Liquid, UPTRAVI, ZERBAXA, YUPELRI, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
